The latest Reclast study emphasizes the importance of treating osteoporosis patients after a hip fracture
The latest Reclast study emphasizes the importance of treating osteoporosis patients after a hip fracture.
Elderly patients who break a hip have a high risk of disability, future fractures, and even death.
Now there's evidence that Reclast (zoledronic acid) reduces the risk of a second fracture and improves survival in these patients.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote